|
STOCKHOLDERS' DEFICIT (Details Textual) (USD $)
|
1 Months Ended | 3 Months Ended | 12 Months Ended | 24 Months Ended | 12 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2013
|
Dec. 31, 2013
|
Mar. 26, 2013
|
Dec. 31, 2012
|
Jan. 14, 2013
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
Nov. 08, 2013
|
Sep. 30, 2013
Ten Vendors [Member]
|
Sep. 30, 2012
Before Amendment [Member]
|
Sep. 30, 2012
After Amendment [Member]
|
Sep. 30, 2013
$1 Notes [Member]
|
Dec. 31, 2012
October 2012 Note [Member]
|
Sep. 30, 2012
October 2012 Note [Member]
|
Dec. 31, 2013
October 2012 Note [Member]
|
Nov. 30, 2012
October 2012 Note [Member]
|
Mar. 26, 2013
Private Placement [Member]
|
Dec. 31, 2012
Forfeiture and Exchange Agreements [Member]
|
Sep. 30, 2012
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2013
Plan 2012 [Member]
|
Mar. 22, 2012
Plan 2012 [Member]
|
Mar. 31, 2010
Plan 2006 [Member]
|
Sep. 30, 2011
Plan 2006 [Member]
|
Sep. 30, 2006
Plan 2006 [Member]
|
Jun. 03, 2011
Plan 2006 [Member]
|
Aug. 03, 2006
Plan 2006 [Member]
|
Mar. 31, 2013
Amendment Plan 2012 [Member]
|
Dec. 31, 2013
Amendment Plan 2006 [Member]
|
Dec. 31, 2013
2012 Omnibus Incentive Compensation Plan [Member]
|
Dec. 31, 2013
Minimum [Member]
|
Mar. 26, 2013
Minimum [Member]
|
Dec. 31, 2012
Minimum [Member]
|
Jan. 14, 2013
Minimum [Member]
|
Dec. 31, 2012
Minimum [Member]
Plan 2012 [Member]
|
Mar. 26, 2013
Minimum [Member]
Amendment Plan 2012 [Member]
|
Dec. 31, 2013
Maximum [Member]
|
Mar. 26, 2013
Maximum [Member]
|
Dec. 31, 2012
Maximum [Member]
|
Jan. 14, 2013
Maximum [Member]
|
Dec. 31, 2012
Maximum [Member]
Plan 2012 [Member]
|
Mar. 26, 2013
Maximum [Member]
Amendment Plan 2012 [Member]
|
Dec. 31, 2013
Monarch Capital Group Llc [Member]
|
Dec. 31, 2013
Monarch Capital Group Llc [Member]
October 2012 Note [Member]
|
Dec. 31, 2013
Mr. Tony Pullen [Member]
October 2012 Note [Member]
|
Dec. 31, 2013
Accredited Third Party Investor [Member]
October 2012 Note [Member]
|
Mar. 26, 2013
Accredited Third Party Investor [Member]
Private Placement [Member]
|
Sep. 30, 2013
Nineteen Accredited Investors [Member]
Private Placement [Member]
|
Sep. 30, 2012
Paul Buck [Member]
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2012
Paul Buck [Member]
Plan 2012 [Member]
|
Jan. 31, 2013
Key Consultants [Member]
|
Sep. 30, 2012
Blu Mont Capital Corp [Member]
|
Dec. 31, 2013
Accredited Investor [Member]
|
Sep. 30, 2013
Twenty Three Accredited Investors [Member]
Private Placement [Member]
|
Dec. 31, 2013
Twenty Three Accredited Investors [Member]
Private Placement [Member]
|
Dec. 31, 2013
Eleven Accredited Investors [Member]
Private Placement [Member]
|
Dec. 31, 2013
Sixteen Accredited Investors [Member]
|
Sep. 30, 2013
SAIL Capital Partners [Member]
Senior Notes [Member]
|
Mar. 22, 2012
Director One [Member]
|
Mar. 22, 2012
Director Two [Member]
|
Dec. 31, 2013
George Carpenter [Member]
|
Sep. 30, 2012
George Carpenter [Member]
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2012
George Carpenter [Member]
Plan 2012 [Member]
|
Sep. 30, 2012
Michael Darkoch [Member]
Forfeiture and Exchange Agreements [Member]
|
Dec. 31, 2012
Michael Darkoch [Member]
Plan 2012 [Member]
|
Dec. 31, 2013
Three Existing and Four New Board [Member]
Plan 2012 [Member]
|
Dec. 31, 2012
Five Former Directors [Member]
Plan 2012 [Member]
|
Dec. 31, 2013
Staff [Member]
|
Sep. 30, 2013
Staff [Member]
|
Dec. 31, 2013
Mr Paul Buck [Member]
|
Dec. 31, 2013
Stewart Navarre [Member]
|
Dec. 31, 2013
Brian MacDonald [Member]
|
Dec. 31, 2013
Two Creditors [Member]
Common Stock [Member]
|
Dec. 31, 2013
CNS California [Member]
|
Dec. 31, 2013
Colorado CNS Response [Member]
|
Dec. 31, 2013
Neuro-Therapy Clinic Inc [Member]
|
|
| Stockholders' Equity Note [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, shares authorized (in shares) | 100,000,000 | 150,000,000 | 150,000,000 | 150,000,000 | 750,000,000 | 100,000,000 | 80,000,000 | 1,000,000 | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Shares Authorized Increased Number | 150,000,000 | 150,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, shares issued (in shares) | 96,062,942 | 92,716,562 | 92,716,562 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, shares outstanding (in shares) | 96,062,942 | 92,716,562 | 92,716,562 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Shares Authorized | 15,000,000 | 15,000,000 | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock, Capital Shares Reserved for Future Issuance | 333,334 | 666,667 | 333,334 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee | 133,333 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms | The option price for each share of stock subject to an option shall be (i) no less than the fair market value of a share of stock on the date the option is granted, if the option is an ISO, or (ii) no less than 85% of the fair market value of the stock on the date the option is granted, if the option is a NSO; provided, however, if the option is an ISO granted to an eligible employee who is a 10% shareholder, the option price for each share of stock subject to such ISO shall be no less than 110% of the fair market value of a share of stock on the date such ISO is granted. Stock options have a maximum term of ten years from the date of grant, except for ISOs granted to an eligible employee who is a 10% shareholder, in which case the maximum term is five years from the date of grant. ISOs may be granted only to eligible employees. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares, Granted | 2,300,000 | 9,247,670 | 250,000 | 1,600,000 | 1,960,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | 42,670 | 439,689 | 8,334 | 8,334 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Exercise Price | $ 3.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance | 12,049,594 | 9,749,594 | 9,749,594 | 501,924 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 6,132 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit | $ 3.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit | $ 32.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants Outstanding Exercise Price | $ 0.04718 | $ 9.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | $ 921,532 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 5,250,406 | 87,786 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Conversion, Original Debt, Amount | 11,273,100 | 11,275,000 | 7,723,300 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Instrument, Face Amount | 5,000,000 | 75,000 | 60,000 | 350,000 | 510,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Employee Compensation Amount Of Waiver | 66,083 | 56,250 | 43,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares Issued In Consideration For Waiver | 66,083 | 56,250 | 43,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Employee Compensation Payment Terms | Any remaining accrued salary remains outstanding and shall be paid (i) from time to time at the discretion of the Board of Directors to the extent the Board of Directors determines that such payment will not jeopardize the ability of the Company to continue as a going concern; or (ii) upon the closing of any single financing transaction (including a single financing transaction that contemplates multiple closings) in which the Company receives proceeds of $5 million or more. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 333,334 | 5,500,000 | 5,500,000 | 15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 1,400,000 | 1,200,000 | 920,000 | 250,000 | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted Average Exercise Price, Granted | $ 0.25 | $ 0.04718 | $ 0.25 | $ 0.25 | $ 0.04718 | $ 0.04718 | $ 0.04718 | $ 0.04718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 36 months | 36 months | 36 months | 48 months | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | 12.50% | 12.50% | 12.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Volume Of Shares Traded On Open Market | 180,000 | 283,400 | 15,000 | 36,700 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trading Days | 51 days | 22 days | 11 days | 21 days | 93 days | 58 days | 48 days | 50 days | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Per Share Value Of Shares Traded On Open Market | $ 0.30 | $ 0.46 | $ 0.76 | $ 0.49 | $ 1.74 | $ 0.83 | $ 0.83 | $ 2.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Convertible Notes Payable | 398,100 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Instrument, Convertible, Conversion Price | $ 1.00 | $ 0.25 | $ 0.25 | $ 0.25 | $ 1.00 | $ 0.04718 | $ 0.04718 | $ 0.04718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock issued for purchase of common stock (in shares) | 4,180,000 | 8,000,000 | 1,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Issue Price Per Share | $ 0.001 | $ 0.25 | $ 0.25 | $ 0.25 | $ 0.25 | $ 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Proceeds from Issuance of Private Placement | 2,500,000 | 695,000 | 1,045,000 | 2,047,500 | 2,000,000 | 475,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number Of Accredited Investors | 19 | 23 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Stock Shares Authorized | 165,000,000 | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Conversion, Converted Instrument, Shares Issued | 76,448,279 | 76,488,279 | 30,893,419 | 40,000 | 40,000 | 1,469,816 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period, Value Issued For Lieu Of Cash To Creditors | 502,100 | 1,466,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period, Shares Issued For Lieu Of Cash To Creditors | 2,008,318 | 1,446,380 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Conversion Original Debt Interest Amount | 1,661,000 | 1,661,100 | 1,359,400 | 50,000 | 219,800 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Instrument Convertible Conversion Price Before Amendment | $ 1.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Instrument Convertible Conversion Price After Amendment | $ 0.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Conversion Original Debt Principal Amount | 9,612,100 | 9,613,900 | 6,363,900 | 1,900 | 1,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity, Reverse Stock Split | 1-for-30 reverse stock split | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Options to purchase shares of common stock | 700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Exercise Price Per Share | $ 0.25 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Extinguishment Of Salaries | $ 98,000 | $ 106,500 | $ 83,600 | $ 66,700 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Extinguishment Of Salaries Percentage | 50.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period | 0 | 70,825 | 435,000 | 470,000 | 385,000 | 310,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||